Showing results (351-360 of 650) with videos related to

Sort By:
Pageof 65
Epidemiology (Cambridge, Mass.)|June 8, 2011
Prediction of serotypes causing invasive pneumococcal disease in unvaccinated and vaccinated populationsDaniel M Weinberger, Zitta B Harboe, Stefan Flasche, et al.
JAMA Network Open|May 7, 2020
Estimated Demand for US Hospital Inpatient and Intensive Care Unit Beds for Patients With COVID-19 Based on Comparisons With Wuhan and Guangzhou, ChinaRuoran Li, Caitlin Rivers, Qi Tan, et al.
Elife|May 18, 2021
Modeling the impact of racial and ethnic disparities on COVID-19 epidemic dynamicsKevin C Ma, Tigist F Menkir, Stephen Kissler, et al.
Epidemiology and Infection|October 26, 2022
Prescribing for different antibiotic classes across age groups in the Kaiser Permanente Northern California population in association with influenza incidence, 2010-2018Edward Goldstein, Bruce H Fireman, Nicola P Klein, et al.
Infection and Immunity|April 9, 2008
Protection against nasopharyngeal colonization by Streptococcus pneumoniae is mediated by antigen-specific CD4+ T cellsKrzysztof Trzciński, Claudette M Thompson, Amit Srivastava, et al.
Journal of Clinical Microbiology|November 28, 2007
In vitro bactericidal activity of Streptococcus pneumoniae and bactericidal susceptibility of Staphylococcus aureus strains isolated from cocolonized versus noncocolonized childrenGili Regev-Yochay, Richard Malley, Ethan Rubinstein, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 12, 2017
Pan-serotype Reduction in Progression of Streptococcus pneumoniae to Otitis Media After Rollout of Pneumococcal Conjugate VaccinesJoseph A Lewnard, Noga Givon-Lavi, Daniel M Weinberger, et al.
The Journal of Infectious Diseases|April 6, 2006
Incremental increase in fitness cost with increased beta -lactam resistance in pneumococci evaluated by competition in an infant rat nasal colonization modelKrzysztof Trzcinski, Claudette M Thompson, Andrea M Gilbey, et al.
Biosecurity and Bioterrorism : Biodefense Strategy, Practice, and Science|May 27, 2011
Improving the evidence base for decision making during a pandemic: the example of 2009 influenza A/H1N1Marc Lipsitch, Lyn Finelli, Richard T Heffernan, et al.
The Lancet. Respiratory Medicine|May 13, 2014
Effect of 13-valent pneumococcal conjugate vaccine on admissions to hospital 2 years after its introduction in the USA: a time series analysisLone Simonsen, Robert J Taylor, Cynthia Schuck-Paim, et al.
Pageof 65